Viewing nowTelmican Tablet 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201209573 · Approved 2012.12.12 · Insurance code 645403890
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
This medication is used for the treatment of essential hypertension, which is hypertension of unknown origin. It also helps decrease the risk of cardiovascular complications such as myocardial infarction and stroke, particularly in patients aged 55 or older who are at high risk of cardiovascular disease. This includes patients with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, as well as those with high-risk diabetes. It is designed to be safely administered even when angiotensin-converting enzyme inhibitors cannot be used. Therefore, this medication is effective not only in managing hypertension but also in protecting cardiovascular health, improving the risk of hypertension and cardiovascular disease.
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After starting treatment, the maximum blood pressure-lowering effect is achieved within 4 ∼ 8 weeks when the dose is increased. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can pose serious risks to the fetus and newborn during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Patients with severely impaired liver function or problems with bile excretion should also avoid its use. Patients with allergies to this medication or its components, as well as those with hereditary angioedema, should not use it. Caution is needed for patients with diabetes or severe kidney disease, as concomitant use with certain medications may be hazardous. Caution is also advised for the elderly or patients with high potassium levels or mildly impaired liver function. Patients with heart or vascular diseases should be careful while taking this medication as excessive decreases in blood pressure may result in complications. Patients with gastrointestinal diseases need to be aware of the risk of gastrointestinal bleeding. Those with renal vascular issues should also avoid use due to the risk of renal function decline. This medication lowers blood pressure; thus, symptoms like hypotension, dizziness, and fainting may occur, and immediate consultation with healthcare providers is necessary if such symptoms arise. Regular blood tests are essential to monitor potential increases in potassium levels. If severe adverse reactions like liver dysfunction, skin rashes, or respiratory distress occur, medication should be discontinued immediately and a hospital visit is required. This medication may interact with other antihypertensives, certain diuretics, and potassium supplements, so it's crucial to inform your healthcare provider about other medications you are taking. Caution is advised when driving or operating machinery due to risks of dizziness or fainting. In cases of overdose, hypotension, arrhythmias, or worsening renal function may occur, requiring immediate medical attention. It is not recommended for children as safety and efficacy have not been established. This medication should be stored out of reach of children, protected from moisture and direct sunlight.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at room temperature between 1 degree and 30 degrees Celsius. Proper storage can help maintain the efficacy and safety of the medication.
A white or almost white, biconvex, round tablet
30 tablets (10 tablets/Alu-Alu x 3), 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.